DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans

Journal Article · · PLoS Pathogens

Viral glycoproteins are a primary target for host antibody responses. However, glycans on viral glycoproteins can hinder antibody recognition since they are self glycans derived from the host biosynthesis pathway. During natural HIV-1 infection, neutralizing antibodies are made against glycans on HIV-1 envelope glycoprotein (Env). However, such antibodies are rarely elicited with vaccination. Previously, the vaccine-induced, macaque antibody DH501 was isolated and shown to bind to high mannose glycans on HIV-1 Env. Understanding how DH501 underwent affinity maturation to recognize glycans could inform vaccine induction of HIV-1 glycan antibodies. Here, we show that DH501 Env glycan reactivity is mediated by both germline-encoded residues that contact glycans, and somatic mutations that increase antibody paratope flexibility. Only somatic mutations in the heavy chain were required for glycan reactivity. The paratope conformation was fragile as single mutations within the immunoglobulin fold or complementarity determining regions were sufficient for eliminating antibody function. Taken together, the initial germline VHDJH rearrangement generated contact residues capable of binding glycans, and somatic mutations were required to form a flexible paratope with a cavity conducive to HIV-1 envelope glycan binding. The requirement for the presence of most somatic mutations across the heavy chain variable region provides one explanation for the difficulty in inducing anti-Env glycan antibodies with HIV-1 Env vaccination.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
W-31109-ENG-38
OSTI ID:
1854209
Journal Information:
PLoS Pathogens, Journal Name: PLoS Pathogens Journal Issue: 12 Vol. 15; ISSN 1553-7374
Publisher:
Public Library of ScienceCopyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (145)

CHARMM-GUI: A web-based graphical user interface for CHARMM journal March 2008
Mutational Impact on “in-Between-Ring” (IBR) Domain of PARKIN on Protein Stability and Function journal January 2021
Proline kinks in transmembrane α-helices journal April 1991
A complete immunoglobulin gene is created by somatic recombination journal September 1978
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH journal April 1980
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization journal March 2013
Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines journal March 2018
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein journal March 2016
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates journal February 2017
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models journal December 2017
Antibody response to Candida albicans cell wall antigens journal July 2004
Increasing Protein Conformational Stability by Optimizing β-Turn Sequence journal October 2007
Virus glycosylation: role in virulence and immune interactions journal May 2007
The Thermal Stability of Immunoglobulin: Unfolding and Aggregation of a Multi-Domain Protein journal January 2000
Effects of ammonium sulfate on the unfolding and refolding of the variable and constant fragments of an immunoglobulin light chain journal March 1988
Glycosylation Site-Specific Analysis of HIV Envelope Proteins (JR-FL and CON-S) Reveals Major Differences in Glycosylation Site Occupancy, Glycoform Profiles, and Antigenic Epitopesʼ Accessibility journal April 2008
The joining of V and J gene segments creates antibody diversity journal January 1980
Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes journal April 1981
Replacing the complementarity-determining regions in a human antibody with those from a mouse journal May 1986
Antibody neutralization and escape by HIV-1 journal March 2003
Broad neutralization coverage of HIV by multiple highly potent antibodies journal September 2011
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 journal November 2011
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges journal April 2016
Carbohydrate vaccines: developing sweet solutions to sticky situations? journal April 2010
Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region journal November 2010
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 journal May 2013
Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity journal November 2017
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope journal March 2018
Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies journal February 2019
High frequency of shared clonotypes in human B cell receptor repertoires journal February 2019
A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity journal September 2010
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120 journal June 2012
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo journal October 2012
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies journal October 2012
Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization journal April 2016
Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment. journal June 1996
Features and development of Coot journal March 2010
Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer journal September 2015
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition journal June 2003
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target journal September 2009
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 journal July 2010
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield journal October 2011
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor journal July 2014
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies journal March 2017
A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120 journal April 2008
An Engineered Saccharomyces cerevisiae Strain Binds the Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody 2G12 and Elicits Mannose-Specific gp120-Binding Antibodies journal July 2008
Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16 journal August 2010
Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140 journal May 2015
Structure of 2G12 Fab2 in Complex with Soluble and Fully Glycosylated HIV-1 Env by Negative-Stain Single-Particle Electron Microscopy journal June 2014
Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope journal November 2014
Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design journal February 2012
Three-Dimensional Structure of Immunoglobulins journal June 1979
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine journal May 2010
Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors journal January 2013
The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade journal August 2011
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers journal May 2009
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies journal September 2013
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design journal August 2016
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting journal January 2017
PHENIX: a comprehensive Python-based system for macromolecular structure solution. text January 2010
Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. journalarticle January 2008
Antibodies VRC01 and 10E8 Neutralize HIV-1 with High Breadth and Potency Even with Ig-Framework Regions Substantially Reverted to Germline journal January 2014
CHARMM-GUI: A web-based graphical user interface for CHARMM journal March 2008
Structure validation by Cα geometry: ϕ,ψ and Cβ deviation journal January 2003
Measuring HIV Neutralization in a Luciferase Reporter Gene Assay book January 2009
Proline kinks in transmembrane α-helices journal April 1991
A complete immunoglobulin gene is created by somatic recombination journal September 1978
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH journal April 1980
The Thermal Stability of Immunoglobulin: Unfolding and Aggregation of a Multi-Domain Protein journal January 2000
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. journal June 1990
Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. journal May 1990
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
The Mechanism and Regulation of Chromosomal V(D)J Recombination journal April 2002
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization journal March 2013
Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies journal September 2014
Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines journal March 2018
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein journal March 2016
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates journal February 2017
Antibody response to Candida albicans cell wall antigens journal July 2004
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure journal April 2017
Inhibition of Mammalian Glycan Biosynthesis Produces Non-self Antigens for a Broadly Neutralising, HIV-1 Specific Antibody journal September 2007
Increasing Protein Conformational Stability by Optimizing β-Turn Sequence journal October 2007
Virus glycosylation: role in virulence and immune interactions journal May 2007
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses journal September 2006
Effects of ammonium sulfate on the unfolding and refolding of the variable and constant fragments of an immunoglobulin light chain journal March 1988
Glycosylation Site-Specific Analysis of HIV Envelope Proteins (JR-FL and CON-S) Reveals Major Differences in Glycosylation Site Occupancy, Glycoform Profiles, and Antigenic Epitopesʼ Accessibility journal April 2008
Glycosylation Site-Specific Analysis of Clade C HIV-1 Envelope Proteins journal September 2009
The joining of V and J gene segments creates antibody diversity journal January 1980
Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes journal April 1981
Replacing the complementarity-determining regions in a human antibody with those from a mouse journal May 1986
Antibody neutralization and escape by HIV-1 journal March 2003
Exploiting the defensive sugars of HIV-1 for drug and vaccine design journal April 2007
Broad neutralization coverage of HIV by multiple highly potent antibodies journal September 2011
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 journal November 2011
Structural and genetic basis for development of broadly neutralizing influenza antibodies journal August 2012
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges journal April 2016
Carbohydrate vaccines: developing sweet solutions to sticky situations? journal April 2010
Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region journal November 2010
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 journal May 2013
Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity journal November 2017
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope journal March 2018
Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies journal February 2019
Commonality despite exceptional diversity in the baseline human antibody repertoire journal January 2019
High frequency of shared clonotypes in human B cell receptor repertoires journal February 2019
A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity journal September 2010
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens journal July 2010
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120 journal June 2012
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo journal October 2012
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies journal October 2012
Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization journal April 2016
Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment. journal June 1996
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection journal January 2011
Evolution of the human ABO polymorphism by two complementary selective pressures
  • Seymour, Robert M.; Allan, Martin J.; Pomiankowski, Andrew
  • Proceedings of the Royal Society of London. Series B: Biological Sciences, Vol. 271, Issue 1543 https://doi.org/10.1098/rspb.2004.2674
journal May 2004
Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard journal December 2007
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Features and development of Coot journal March 2010
Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer journal September 2015
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition journal June 2003
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target journal September 2009
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 journal July 2010
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield journal October 2011
Structural Studies of Immunoglobulins journal May 1973
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor journal July 2014
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies journal March 2017
A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120 journal April 2008
An Engineered Saccharomyces cerevisiae Strain Binds the Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody 2G12 and Elicits Mannose-Specific gp120-Binding Antibodies journal July 2008
Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization journal August 2007
Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16 journal August 2010
Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140 journal May 2015
Structure of 2G12 Fab2 in Complex with Soluble and Fully Glycosylated HIV-1 Env by Negative-Stain Single-Particle Electron Microscopy journal June 2014
Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Proteins Incorporated into Infectious Virions journal September 2010
Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope journal November 2014
Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design journal February 2012
Three-Dimensional Structure of Immunoglobulins journal June 1979
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine journal May 2010
Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors journal January 2013
The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade journal August 2011
High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge journal September 2013
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers journal May 2009
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals journal August 2010
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies journal September 2013
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design journal August 2016
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting journal January 2017
Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies journal April 2018
Antibodies VRC01 and 10E8 Neutralize HIV-1 with High Breadth and Potency Even with Ig-Framework Regions Substantially Reverted to Germline journal January 2014

Cited By (1)

The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans journal February 2020